Various tissue fibroblast types with distinct properties shape the architecture of the specialized niches of the lung (e.g. airways, alveoli, vasculature). In a significant breakthrough, a team led by Gerald Burgstaller and Herbert Schiller from…
A new study led by Helmholtz Munich scientists Ursula Zimber-Strobl and Lothar J. Strobl sheds light on the intricate pathways of B-lymphocyte development during adaptive immune responses. The study, published in Nature Communications, reveals that…
How do ageing and environmental stress promote chronic inflammatory diseases? Maja Funk, new PI at the Institute of Lung Health and Immunity (LHI) at Helmholtz Munich is getting to the bottom of this question. Together with her team, she investigates…
Many cancer patients develop severe dermatitis during radiotherapy. Which factors increase the risk of such radiodermatitis has only been partially understood up until now. A pilot study at the University of Augsburg, Helmholtz Munich, and the…
A collaborative research project between scientists from Helmholtz Munich, Goethe University Frankfurt, Ludwig Maximilian University Munich, and Technion, the Israel Institute of Technology in Haifa, on “Understanding and Targeting…
To mechanistically understand the root causes of lung disease, and identify drugs that target specific pathways, the scientists around Prof. Herbert Schiller and Dr. Gerald Burgstaller from Helmholtz Munich are collecting deep molecular insights from…
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here: